Atrial fibrillation risk in athletes study
Part of Heart & circulation clinical trials.
This study looks at why athletes may have a higher risk of atrial fibrillation (an irregular heartbeat). If you are a competitive athlete with atrial fibrillation, you may be able to help researchers understand this link.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have atrial fibrillation confirmed by an ECG (a heart tracing) that comes and goes or stays for a while.
- You are a competitive athlete: you have done over 1500 hours of moderate to intense endurance sports and competed in at least one event in the last 10 years.
- You do not have permanent atrial fibrillation (constant irregular heartbeat).
- You do not have certain heart conditions like previous heart attack, weak heart muscle, or untreated high blood pressure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a heart procedure (cardiac ablation) helps endurance athletes who have atrial fibrillation (an irregular heartbeat) perform better in sports. Athletes will track their training data before and after the procedure to see if their performance improves.
This study tracks patients with atrial fibrillation (AF) over time to better understand the condition and improve care. You may be asked to share health information and attend follow-up visits.
This study looks at how a very fast heart rate from atrial fibrillation might affect the heart muscle. If you are having symptoms from this condition and haven't had a prior heart attack or stent, you may be able to help researchers understand the link and improve care.
This study looks for unique metabolic patterns in people with atrial fibrillation (an irregular heartbeat). The goal is to develop personalized prevention strategies by comparing these patterns between patients and healthy volunteers.
This study follows people with atrial fibrillation (irregular heartbeat) who also have a metabolic disorder (like diabetes or obesity). Researchers want to learn more about how these conditions interact over time.
This study looks at stroke risk and blood clotting in people who have just been diagnosed with atrial fibrillation (AFib) that is not caused by a heart valve problem, and who have not yet taken blood thinners. It aims to better understand how blood clots form in this condition.
Hear when a new Atrial Fibrillation (AF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.